Do you have the same question? Follow this Question
May 13, 2026 - 08:32 AM
We’ve provided several answers to questions related to Vyepti (Eptinezumab) , see some other helpful Q&A related to this product.
Question: Can this medication be used in children?
Answer: Safety and efficacy have not been established in pediatric patients. This means it should only be used in adults, ensuring appropriate use and minimizing risk in children.
Question: Is this product approved by the US FDA?
Answer: Yes, it is licensed by the US Food and Drug Administration (FDA) since 2020. FDA approval provides assurance of safety, efficacy, and quality.
Question: Does this product contain preservatives?
Answer: No, it is preservative-free and must be diluted prior to use. Preservative-free formulations are valuable for reducing the risk of allergic or adverse reactions in sensitive individuals.
Question: What strengths does this medication come in?
Answer: It is available as 100 mg/mL or 300 mg/100 mL for intravenous infusion. Having multiple strengths allows for personalized dosing and easy preparation for the infusion process.
